Curemark Competitors and Similar CompaniesClear all
Curemark's competitors and similar companies include Synthorx and Incendia Therapeutics.
 Curemark Curemark is a biopharmaceutical company focused on developing therapies for the treatment of neurological and other disorders. |  Synthorx Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics. |  Incendia Therapeutics Incendia Therapeutics (formerly known as Parthenon Therapeutics) is a biotech company that develops anti-cancer therapies for reprogramming the tumor microenvironment. | |
Founding Date | Founding Date 2006 | Founding Date 2014 | Founding Date 2019 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Rye, US HQ Rye Brook, US | Locations San Diego, US HQ | Locations Boston, US HQ |
Employees | Employees 23 | Employees 3939% increase | Employees 41 |
Funding | |||
Latest funding round | Latest funding round $ 5.4m (almost 7 years ago) | Latest funding round N/A | Latest funding round $ 65m (over 4 years ago) |
Total funding raised | Total funding raised $ 55.7m | Total funding raised $ 79m | Total funding raised $ 65m |
For sources of this data, please see the company profile
View Company Profiles
Synthorx
HQ
San Diego, US
Employees
39↑ 39% increase
Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics.
View companyIncendia Therapeutics
HQ
Boston, US
Employees
41
Incendia Therapeutics (formerly known as Parthenon Therapeutics) is a biotech company that develops anti-cancer therapies for reprogramming the tumor microenvironment.
View company